AAPL343.83-3.27 (-0.94%) ▼|ABBV285.99-0.40 (-0.14%) ▼|ABT102.64-0.46 (-0.45%) ▼|ACN243.40+8.24 (+3.50%) ▲|ADBE249.76+1.40 (+0.56%) ▲|AMAT416.00+20.07 (+5.07%) ▲|AMD578.44+18.18 (+3.24%) ▲|AMGN451.83+3.88 (+0.87%) ▲|AMT183.75-0.08 (-0.04%) ▼|AMZN254.60+1.50 (+0.59%) ▲|AVGO351.81+9.48 (+2.77%) ▲|AXP317.94+5.03 (+1.61%) ▲|BA167.14-1.04 (-0.62%) ▼|BAC50.85+0.17 (+0.34%) ▲|BKNG147.94-2.20 (-1.47%) ▼|BLK1,157.88+21.83 (+1.92%) ▲|BMY60.57-0.98 (-1.59%) ▼|BNY148.59+1.01 (+0.68%) ▲|BRK-B540.34-2.65 (-0.49%) ▼|C124.11+1.42 (+1.16%) ▲|CAT713.38+0.07 (+0.01%) ▲|CL91.69-0.48 (-0.52%) ▼|CMCSA21.57-0.27 (-1.24%) ▼|COF204.88+1.44 (+0.71%) ▲|COP149.06+1.10 (+0.74%) ▲|COST982.73-9.40 (-0.95%) ▼|CRM242.11+1.22 (+0.51%) ▲|CSCO110.29-1.09 (-0.98%) ▼|CVS89.95-1.18 (-1.29%) ▼|CVX229.20+0.97 (+0.43%) ▲|DE640.67+1.09 (+0.17%) ▲|DHR234.07+2.07 (+0.89%) ▲|DIS109.04-1.19 (-1.08%) ▼|DUK123.57-1.23 (-0.99%) ▼|EMR167.71+1.44 (+0.87%) ▲|FDX304.58-2.52 (-0.82%) ▼|GD354.35-0.54 (-0.15%) ▼|GE301.13+3.47 (+1.17%) ▲|GEV878.03-17.05 (-1.90%) ▼|GILD159.20+0.12 (+0.08%) ▲|GM82.48+1.94 (+2.41%) ▲|GOOG321.89+5.06 (+1.60%) ▲|GOOGL324.89+4.31 (+1.34%) ▲|GS925.17+13.40 (+1.47%) ▲|HD317.56-0.94 (-0.30%) ▼|HON219.26+0.45 (+0.21%) ▲|IBM253.22+2.97 (+1.19%) ▲|INTC95.53+1.79 (+1.91%) ▲|INTU328.19-0.26 (-0.08%) ▼|ISRG444.18-1.70 (-0.38%) ▼|JNJ271.04+2.31 (+0.86%) ▲|JPM339.30+3.51 (+1.05%) ▲|KO91.73+0.55 (+0.60%) ▲|LIN508.16-0.49 (-0.10%) ▼|LLY1,288.30+6.39 (+0.50%) ▲|LMT629.75+6.76 (+1.09%) ▲|LOW198.40+0.22 (+0.11%) ▲|LRCX253.82+12.97 (+5.39%) ▲|MA610.31+0.46 (+0.08%) ▲|MCD250.50+1.03 (+0.41%) ▲|MDLZ61.87-0.48 (-0.77%) ▼|MDT94.78+0.83 (+0.88%) ▲|META612.49-7.70 (-1.24%) ▼|MMM172.80+1.22 (+0.71%) ▲|MO72.99-0.50 (-0.68%) ▼|MRK140.93-0.89 (-0.63%) ▼|MS190.13+3.22 (+1.72%) ▲|MSFT531.01-0.32 (-0.06%) ▼|MU983.23+54.47 (+5.86%) ▲|NEE81.02-1.40 (-1.70%) ▼|NFLX61.99-0.53 (-0.85%) ▼|NKE37.15-0.41 (-1.09%) ▼|NOW150.13-4.65 (-3.00%) ▼|NVDA215.38-2.56 (-1.17%) ▼|ORCL144.54+14.01 (+10.73%) ▲|PEP132.63-0.87 (-0.65%) ▼|PFE29.45-0.35 (-1.17%) ▼|PG158.26-0.97 (-0.61%) ▼|PLTR196.81-1.92 (-0.97%) ▼|PM202.64+0.02 (+0.01%) ▲|QCOM182.97-1.20 (-0.65%) ▼|RTX195.84+1.24 (+0.64%) ▲|SBUX103.20+0.16 (+0.16%) ▲|SCHW88.76-0.54 (-0.60%) ▼|SO91.52-1.13 (-1.22%) ▼|SPG211.24-1.04 (-0.49%) ▼|T20.70-0.24 (-1.15%) ▼|TMO704.15+11.13 (+1.61%) ▲|TMUS148.08+1.25 (+0.85%) ▲|TSLA404.22-3.24 (-0.80%) ▼|TXN309.83+0.92 (+0.30%) ▲|UBER65.27-0.51 (-0.78%) ▼|UNH407.10-3.29 (-0.80%) ▼|UNP297.80-2.08 (-0.69%) ▼|UPS105.62-0.47 (-0.44%) ▼|USB59.60-0.14 (-0.23%) ▼|V400.60-1.26 (-0.31%) ▼|VZ43.18-0.75 (-1.71%) ▼|WFC83.67+1.01 (+1.22%) ▲|WMT118.77-0.55 (-0.46%) ▼|XOM182.02+2.11 (+1.17%) ▲|AAPL343.83-3.27 (-0.94%) ▼|ABBV285.99-0.40 (-0.14%) ▼|ABT102.64-0.46 (-0.45%) ▼|ACN243.40+8.24 (+3.50%) ▲|ADBE249.76+1.40 (+0.56%) ▲|AMAT416.00+20.07 (+5.07%) ▲|AMD578.44+18.18 (+3.24%) ▲|AMGN451.83+3.88 (+0.87%) ▲|AMT183.75-0.08 (-0.04%) ▼|AMZN254.60+1.50 (+0.59%) ▲|AVGO351.81+9.48 (+2.77%) ▲|AXP317.94+5.03 (+1.61%) ▲|BA167.14-1.04 (-0.62%) ▼|BAC50.85+0.17 (+0.34%) ▲|BKNG147.94-2.20 (-1.47%) ▼|BLK1,157.88+21.83 (+1.92%) ▲|BMY60.57-0.98 (-1.59%) ▼|BNY148.59+1.01 (+0.68%) ▲|BRK-B540.34-2.65 (-0.49%) ▼|C124.11+1.42 (+1.16%) ▲|CAT713.38+0.07 (+0.01%) ▲|CL91.69-0.48 (-0.52%) ▼|CMCSA21.57-0.27 (-1.24%) ▼|COF204.88+1.44 (+0.71%) ▲|COP149.06+1.10 (+0.74%) ▲|COST982.73-9.40 (-0.95%) ▼|CRM242.11+1.22 (+0.51%) ▲|CSCO110.29-1.09 (-0.98%) ▼|CVS89.95-1.18 (-1.29%) ▼|CVX229.20+0.97 (+0.43%) ▲|DE640.67+1.09 (+0.17%) ▲|DHR234.07+2.07 (+0.89%) ▲|DIS109.04-1.19 (-1.08%) ▼|DUK123.57-1.23 (-0.99%) ▼|EMR167.71+1.44 (+0.87%) ▲|FDX304.58-2.52 (-0.82%) ▼|GD354.35-0.54 (-0.15%) ▼|GE301.13+3.47 (+1.17%) ▲|GEV878.03-17.05 (-1.90%) ▼|GILD159.20+0.12 (+0.08%) ▲|GM82.48+1.94 (+2.41%) ▲|GOOG321.89+5.06 (+1.60%) ▲|GOOGL324.89+4.31 (+1.34%) ▲|GS925.17+13.40 (+1.47%) ▲|HD317.56-0.94 (-0.30%) ▼|HON219.26+0.45 (+0.21%) ▲|IBM253.22+2.97 (+1.19%) ▲|INTC95.53+1.79 (+1.91%) ▲|INTU328.19-0.26 (-0.08%) ▼|ISRG444.18-1.70 (-0.38%) ▼|JNJ271.04+2.31 (+0.86%) ▲|JPM339.30+3.51 (+1.05%) ▲|KO91.73+0.55 (+0.60%) ▲|LIN508.16-0.49 (-0.10%) ▼|LLY1,288.30+6.39 (+0.50%) ▲|LMT629.75+6.76 (+1.09%) ▲|LOW198.40+0.22 (+0.11%) ▲|LRCX253.82+12.97 (+5.39%) ▲|MA610.31+0.46 (+0.08%) ▲|MCD250.50+1.03 (+0.41%) ▲|MDLZ61.87-0.48 (-0.77%) ▼|MDT94.78+0.83 (+0.88%) ▲|META612.49-7.70 (-1.24%) ▼|MMM172.80+1.22 (+0.71%) ▲|MO72.99-0.50 (-0.68%) ▼|MRK140.93-0.89 (-0.63%) ▼|MS190.13+3.22 (+1.72%) ▲|MSFT531.01-0.32 (-0.06%) ▼|MU983.23+54.47 (+5.86%) ▲|NEE81.02-1.40 (-1.70%) ▼|NFLX61.99-0.53 (-0.85%) ▼|NKE37.15-0.41 (-1.09%) ▼|NOW150.13-4.65 (-3.00%) ▼|NVDA215.38-2.56 (-1.17%) ▼|ORCL144.54+14.01 (+10.73%) ▲|PEP132.63-0.87 (-0.65%) ▼|PFE29.45-0.35 (-1.17%) ▼|PG158.26-0.97 (-0.61%) ▼|PLTR196.81-1.92 (-0.97%) ▼|PM202.64+0.02 (+0.01%) ▲|QCOM182.97-1.20 (-0.65%) ▼|RTX195.84+1.24 (+0.64%) ▲|SBUX103.20+0.16 (+0.16%) ▲|SCHW88.76-0.54 (-0.60%) ▼|SO91.52-1.13 (-1.22%) ▼|SPG211.24-1.04 (-0.49%) ▼|T20.70-0.24 (-1.15%) ▼|TMO704.15+11.13 (+1.61%) ▲|TMUS148.08+1.25 (+0.85%) ▲|TSLA404.22-3.24 (-0.80%) ▼|TXN309.83+0.92 (+0.30%) ▲|UBER65.27-0.51 (-0.78%) ▼|UNH407.10-3.29 (-0.80%) ▼|UNP297.80-2.08 (-0.69%) ▼|UPS105.62-0.47 (-0.44%) ▼|USB59.60-0.14 (-0.23%) ▼|V400.60-1.26 (-0.31%) ▼|VZ43.18-0.75 (-1.71%) ▼|WFC83.67+1.01 (+1.22%) ▲|WMT118.77-0.55 (-0.46%) ▼|XOM182.02+2.11 (+1.17%) ▲|
11.5 C
New York
Thursday, October 29, 2026

Tag: agents

newsFORsourcecompanycontentinformationreleases1market

Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China

Joincare Group to lead the clinical development and commercialization of BRII-693 in Greater ChinaBrii Biosciences retains ex-Greater China rights to address the global antimicrobial...

Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China

Joincare Group to lead the clinical development and commercialization of BRII-693 in Greater ChinaBrii Biosciences retains ex-Greater China rights to address the global antimicrobial...

Remote Pharmacy Releases 2025 Availability Update on GLP-1 Weight Loss Solutions and Consumer Interest in Semaglutide & Tirzepatide

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management. 
In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management.

High-Potency OTC NMN Supplement from Wonderfeel Launches Amid Surging Demand for Clean NAD+ Support Solutions

Wonderfeel’s 2025 Youngr™ update features a 900mg stabilized NMN dose with antioxidant co-factors, formulated to align with consumer interest in bioavailable, non-synthetic NAD+ wellness support. 
Wonderfeel’s 2025 Youngr™ update features a 900mg stabilized NMN dose with antioxidant co-factors, formulated to align with consumer interest in bioavailable, non-synthetic NAD+ wellness support.

GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight

The GPRC5D-directed therapies market is witnessing robust growth, driven by the high unmet need in relapsed/refractory multiple myeloma. Innovative modalities like CAR-T cells, bispecific...

GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight

The GPRC5D-directed therapies market is witnessing robust growth, driven by the high unmet need in relapsed/refractory multiple myeloma. Innovative modalities like CAR-T cells, bispecific...

Gluco6 Recognized for Strong Ingredient Transparency and OTC GLUT-4 Nutritional Support

Featuring Sukre™ for GLUT-4 Receptor Support, Gluco6 Highlights Non-Synthetic Compounds and 2025 Trends in Plant-Based Glucose Wellness 
Featuring Sukre™ for GLUT-4 Receptor Support, Gluco6 Highlights Non-Synthetic Compounds and 2025 Trends in Plant-Based Glucose Wellness

Bioma Probiotics Redefines Digestive Health in 2025 With Its Strongest Prebiotic, Probiotic, and Postbiotic Synergy Yet

Bioma’s transparency-driven formula highlights XOS prebiotics, targeted Bifidobacterium strains, and tributyrin postbiotics—meeting rising consumer demand for non-synthetic gut health support without promotional claims. 
Bioma’s transparency-driven formula highlights XOS prebiotics, targeted Bifidobacterium strains, and tributyrin postbiotics—meeting rising consumer demand for non-synthetic gut health support without promotional claims.

PhenQ Updates 2025 Formula With Strongest OTC Appetite Suppressant Profile and Clinically Studied Craving Support Ingredients

Now Reformulated With InnoSlim®, α-Lacys Reset®, and Capsimax® to Support Multi-Pathway Metabolic Function Without a Prescription 
Now Reformulated With InnoSlim®, α-Lacys Reset®, and Capsimax® to Support Multi-Pathway Metabolic Function Without a Prescription

Auto Theft Claims Rise in Alberta, Deepening Strain on Insurance Market: IBC Urges Action

EDMONTON, AB, July 3, 2025 /CNW/ - Newly released data from Insurance Bureau of Canada (IBC) shows that the cost of auto theft continued to...

La Rosa Holdings Corp. Announces Significant Milestone: Surpasses 3,000 Agents and Reports Preliminary Unaudited Revenue of $38.4 Million for the First Half of 2025,...

Celebration, FL, July 03, 2025 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech company, today announced a major milestone in its growth trajectory, surpassing 3,000 real estate agents across its network. The Company also reported preliminary unaudited revenue of approximately $38.4 million for the first half of 2025, representing approximately 19.4% year-over-year growth compared to the same period in 2024.

Magna5 Ranks #39 on Channel Partners 2025 MSP 501 List

Recognized Among the World's Elite Managed Service Providers PITTSBURGH, July 3, 2025 /PRNewswire/ -- Magna5 has been ranked #39 on the highly competitive 2025 Channel Partners...

Innovative Molecules Offer Good News in the Fight Against HIV and Other Viral Infections

INRS team is exploring the potential of saponins, a group of natural molecules found in many plants LAVAL, QC, July 3, 2025 /CNW/ - Innovative, nontoxic...

Bound’s Publishing Course is building the next generation of creative professionals

MUMBAI, India, July 3, 2025 /PRNewswire/ -- Bound, India's leading creative education platform, announces the next edition of The Bound Publishing Course, a first-of-its-kind,...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAgents

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers